Literature DB >> 3067025

Genetic polymorphism of enzymes of alcohol metabolism and susceptibility to alcoholic liver disease.

W F Bosron1, L Lumeng, T K Li.   

Abstract

Differences in the pharmacokinetics of alcohol absorption and elimination are, in part, genetically determined. There are polymorphic variants of the two main enzymes responsible for ethanol oxidation in liver, alcohol dehydrogenase and aldehyde dehydrogenase. The frequency of occurrence of these variants, which have been shown to display strikingly different catalytic properties, differs among different racial populations. Since the activity of alcohol dehydrogenase in liver is a rate-limiting factor for ethanol metabolism in experimental animals, it is likely that the type and content of the polymorphic isoenzyme subunit encoded at ADH2, beta-subunit, and at ADH3, the gamma-subunit, are contributing factors to the genetic variability in ethanol elimination rate. The recent development of methods for genotyping individuals at these loci using white cell DNA will allow us to test this hypothesis as well as any relationship between ADH genotype and the susceptibility to alcoholism or alcohol-related pathology. A polymorphic variant of human liver mitochondrial aldehyde dehydrogenase, ADLH2, which has little or no acetaldehyde oxidizing activity has been identified. Individuals with the deficient ALDH2 phenotype do not have altered ethanol elimination rates but they do exhibit high blood acetaldehyde levels and dysphoric symptoms such as facial flushing, nausea and tachycardia, after drinking alcohol. Because acetaldehyde is so reactive, it binds to free amino groups of proteins including a 37 kilodalton hepatic protein-acetaldehyde adduct and may elicit an antibody response. We would predict that individuals who have low ALDH2 activity because of liver disease or because they have the inactive ALDH2 variant isoenzyme might form more protein-acetaldehyde adducts and elicit a greater immune response. These adducts may represent good biological markers of alcohol abuse and may also play a role in liver injury due to chronic alcohol consumption.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3067025     DOI: 10.1016/0098-2997(88)90019-2

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  17 in total

Review 1.  Moderate alcohol consumption and coronary heart disease: a review.

Authors:  L M Hines; E B Rimm
Journal:  Postgrad Med J       Date:  2001-12       Impact factor: 2.401

2.  Associations between aldehyde dehydrogenase 2 (ALDH2) genetic polymorphisms, drinking status, and hypertension risk in Japanese adult male workers: a case-control study.

Authors:  Mitsunori Ota; Aya Hisada; Xi Lu; Chihiro Nakashita; Shouta Masuda; Takahiko Katoh
Journal:  Environ Health Prev Med       Date:  2015-08-30       Impact factor: 3.674

Review 3.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

4.  Alcohol dehydrogenase 1C (ADH1C) gene polymorphism and alcoholic liver cirrhosis risk: a meta analysis.

Authors:  Lei He; Tao Deng; He-Sheng Luo
Journal:  Int J Clin Exp Med       Date:  2015-07-15

5.  Alcohol and aldehyde dehydrogenase polymorphisms in Japanese patients with alcohol-induced chronic pancreatitis.

Authors:  S Kimura; Y Okabayashi; K Inushima; T Kochi; Y Yutsudo; M Kasuga
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

6.  Greater hepatic vulnerability after alcohol intake in African Americans compared with Caucasians: a population-based study.

Authors:  Saverio Stranges; Jo L Freudenheim; Paola Muti; Eduardo Farinaro; Marcia Russell; Thomas H Nochajski; Maurizio Trevisan
Journal:  J Natl Med Assoc       Date:  2004-09       Impact factor: 1.798

7.  Cancer stem cells in head and neck squamous cell carcinoma.

Authors:  Marcus M Monroe; Eric C Anderson; Daniel R Clayburgh; Melissa H Wong
Journal:  J Oncol       Date:  2010-11-08       Impact factor: 4.375

8.  Polymorphisms of alcohol dehydrogenase-2 and aldehyde dehydrogenase-2 and esophageal cancer risk in Southeast Chinese males.

Authors:  Jian-Hua Ding; Su-Ping Li; Hai-Xia Cao; Jian-Zhong Wu; Chang-Ming Gao; Ping Su; Yan-Ting Liu; Jian-Nong Zhou; Jun Chang; Gen-Hong Yao
Journal:  World J Gastroenterol       Date:  2009-05-21       Impact factor: 5.742

9.  Structure of human beta 1 beta 1 alcohol dehydrogenase: catalytic effects of non-active-site substitutions.

Authors:  T D Hurley; W F Bosron; J A Hamilton; L M Amzel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

10.  Association of ADH1B and ALDH2 gene polymorphisms with alcohol dependence: a pilot study from India.

Authors:  Meera Vaswani; Pushplata Prasad; Suman Kapur
Journal:  Hum Genomics       Date:  2009-04       Impact factor: 4.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.